Skip to main content

Advertisement

SpringerLink
Log in

Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Rosai J, Dorfman RF (1969) Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 87(1):63–70

    CAS  PubMed  Google Scholar 

  2. Foucar E, Rosai J, Dorfman R (1990) Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 7(1):19–73

    CAS  PubMed  Google Scholar 

  3. Cai Y, Shi Z, Bai Y (2017) Review of Rosai-Dorfman disease: new insights into the pathogenesis of this rare disorder. Acta Haematol 138(1):14–23

    Article  CAS  PubMed  Google Scholar 

  4. Jacobsen E, Shanmugam V, Jagannathan J (2017) Rosai-Dorfman disease with activating KRAS mutation—response to cobimetinib. N Engl J Med 377(24):2398–2399

    Article  PubMed  Google Scholar 

  5. Oka M et al (2009) Successful treatment of Rosai-Dorfman disease with low-dose oral corticosteroid. J Dermatol 36(4):237–240

    Article  PubMed  Google Scholar 

  6. Dalia S, Sagatys E, Sokol L, Kubal T (2014) Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control 21(4):322–327

    Article  PubMed  Google Scholar 

  7. Zhao M, Li C, Zheng J, Yu J, Sha H, Yan M, Jin J, Sun K, Wang Z (2013) Extranodal Rosai-Dorfman disease involving appendix and mesenteric nodes with a protracted course: report of a rare case lacking relationship to IgG4-related disease and review of the literature. Int J Clin Exp Pathol 6(11):2569–2577

    PubMed  PubMed Central  Google Scholar 

  8. Scheel MM, Rady PL, Tyring SK, Pandya AG (1997) Sinus histiocytosis with massive lymphadenopathy: presentation as giant granuloma annulare and detection of human herpesvirus 6. J Am Acad Dermatol 37(4):643–646

    Article  CAS  PubMed  Google Scholar 

  9. Pagel JM, Lionberger J, Gopal AK, Sabath DE, Loeb K (2007) Therapeutic use of rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Am J Hematol 82(12):1121–1122

    Article  PubMed  Google Scholar 

  10. Lohr HF et al (1995) Long-term survival in a patient with Rosai-Dorfman disease treated with interferon-alpha. Eur J Cancer 31a(13–14):2427–2428

    Article  CAS  PubMed  Google Scholar 

  11. Maia RC, de Meis E, Romano S, Dobbin JA, Klumb CE (2015) Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature. Braz J Med Biol Res 48(1):6–12

    Article  CAS  PubMed  Google Scholar 

  12. Cao XX, Sun J, Li J, Zhong DR, Niu N, Duan MH, Liang ZY, Zhou DB (2016) Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults. Ann Hematol 95(5):745–750

    Article  CAS  PubMed  Google Scholar 

  13. Go H, Jeon YK, Huh J, Choi SJ, Choi YD, Cha HJ, Kim HJ, Park G, Min S, Kim JE (2014) Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology 65(2):261–272

    Article  PubMed  Google Scholar 

  14. Simko SJ, Tran HD, Jones J, Bilgi M, Beaupin LK, Coulter D, Garrington T, McCavit TL, Moore C, Rivera-Ortegón F, Shaffer L, Stork L, Turcotte L, Welsh EC, Hicks MJ, McClain KL, Allen CE (2014) Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatr Blood Cancer 61(3):479–487

    Article  CAS  PubMed  Google Scholar 

  15. Eckstein O, Bingham R, Peckham EC, Brown A, Allen CE, McClain KL (2016) Efficacy and toxicity profile of clofarabine in patients with recurrent/refractory Langerhans cell histiocytosis and other histiocytic disorders. Blood 128:1329

    Article  CAS  Google Scholar 

Download references

Contributions

MM and CRG prepared the manuscript assisted by CH. HGK, MH, LQMF, MH, and SW made clinical data available. CH, MS, KM, KPK, and JH extracted the medical records. CH, MS, and DD prepared the first draft of the manuscript. LK gave important advice during the treatment of the patient and the preparation of the manuscript. All authors had access to the data and a role in writing this manuscript.

Author information

Authors and Affiliations

  1. Department of Oncology, Hematology and Immunology, University of Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany

    Clemens Hinterleitner, Martina Steurer, Daniela Dörfel, Jonas Heitmann, Klaus-Peter Kreisselmeier, Hans-Georg Kopp, Stefan Wirths, Lothar Kanz & Martin R. Müller

  2. Department of Cardiology, University of Tübingen, Tübingen, Germany

    Karin Müller

  3. Department of Endocrinology, Diabetology, Clinical Pathology and Metabolism, University of Tübingen, Tübingen, Germany

    Michael Haap

  4. Department of Pathology and Neuropathology, University of Tübingen, Tübingen, Germany

    Leticia Quintanilla-Martinez de Fend

  5. Department of Radiology, University of Tübingen, Tübingen, Germany

    Marius Horger

  6. Department of Global Pediatric Medicine, St. Jude’s Children Research Hospital, Memphis, TN, USA

    Carlos Rodriguez-Galindo

  7. Department of Oncology, Hematology and Immunology, Klinikum Siloah, Hannover, Germany

    Martin R. Müller

Authors
  1. Clemens Hinterleitner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martina Steurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniela Dörfel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonas Heitmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Klaus-Peter Kreisselmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Karin Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hans-Georg Kopp
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Stefan Wirths
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michael Haap
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Leticia Quintanilla-Martinez de Fend
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Marius Horger
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Carlos Rodriguez-Galindo
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Lothar Kanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Martin R. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin R. Müller.

Ethics declarations

After obtaining written informed consent from the patient, this case study was performed in accordance with the Declaration of Helsinki.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hinterleitner, C., Steurer, M., Dörfel, D. et al. Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient. Ann Hematol 98, 227–230 (2019). https://doi.org/10.1007/s00277-018-3421-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-018-3421-7

Search

Navigation